Back to Search Start Over

FERALGINEā„¢ a New Oral iron Compound

Authors :
Giuseppe Antonio Mazza
Laura Giancotti
Marco Bertini
Santina Marrazzo
Roberto Miniero
Valentina Talarico
Source :
Iron Metabolism-A Double-Edged Sword, Iron Metabolism-A Double-Edged Sword ISBN: 9781839629976
Publication Year :
2021
Publisher :
IntechOpen, 2021.

Abstract

Management of iron deficiency (ID) and iron deficiency anemia (IDA) is primarily focused to remove, when possible, the underlying cause of ID; subsequently its treatment is primary focused on iron stores repletion. Ferrous sulphate (FS) remains the mainstay of treatment and it is recommended as the first-line treatment of ID and IDA in children as in adults by all guidelines of scientific societies. However the effectiveness of FS is largely compromised by increased adverse effects, poor compliance and discontinuation of treatment. A new oral iron source named FERALGINEā„¢ (FBC-A) has been recently developed. This new molecule is a patented co-processed one-to-one ratio compound between Ferrous Bysglicinate Chelate (FBC) and Sodium Alginate (AA), obtained by using a spray drying technology. The data presented in this short review highlight the efficacy and safety of the treatment with FBC-A and support its use in adult patients with IDA. Furthermore the present review also provides preliminary evidence to suggest FBC-A as first-line treatment for ID/IDA in patients with celiac disease (CD) or inflammatory bowel diseases (IBD).

Subjects

Subjects :
business.industry
Medicine
business

Details

Language :
English
ISBN :
978-1-83962-997-6
ISBNs :
9781839629976
Database :
OpenAIRE
Journal :
Iron Metabolism-A Double-Edged Sword, Iron Metabolism-A Double-Edged Sword ISBN: 9781839629976
Accession number :
edsair.doi.dedup.....9c2568ff2dc809fa10ec5d98a3e6339b